Erufosine, a novel alkylphosphocholine, in acute myeloid leukemia: single activity and combination with other antileukemic drugs

被引：0
|
作者：
Michael Fiegl
Lars H. Lindner
Matthias Juergens
Hansjoerg Eibl
Wolfgang Hiddemann
Jan Braess
机构：
[1] Ludwig-Maximilians University,Laboratory for Leukemia Diagnostics, Department of Internal Medicine III, University Hospital Grosshadern
[2] GSF-National Research Center for Environment and Health,Institute of Molecular Immunology
[3] GSF-National Research Center for Environment and Health,Clinical Cooperative Group Acute Myeloid Leukemia
[4] Max Planck Institute for Biophysical Chemistry,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2008年 / 62卷
关键词：
AML; Alkylphosphocholine; Cytarabine; Cytotoxicity; Interaction analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：321 / 329
页数：8
相关论文
共 50 条
  • [21] Antileukemic action of (-)-epicatechin in the spleen of rats with acute myeloid leukemia
    Papiez, M. A.
    Baran, J.
    Bukowska-Strakova, K.
    Wiczkowski, W.
    FOOD AND CHEMICAL TOXICOLOGY, 2010, 48 (12) : 3391 - 3397
  • [22] Dronabinol has preferential antileukemic activity in acute lymphoblastic and myeloid leukemia with lymphoid differentiation patterns
    Kampa-Schittenhelm, Kerstin Maria
    Salitzky, Olaf
    Akmut, Figen
    Illing, Barbara
    Kanz, Lothar
    Salih, Helmut Rainer
    Schittenhelm, Marcus Matthias, I
    BMC CANCER, 2016, 16
  • [23] BET Inhibition Enhances the Antileukemic Activity of Low-dose Venetoclax in Acute Myeloid Leukemia
    Ramsey, Haley E.
    Greenwood, Dalton
    Zhang, Susu
    Childress, Merrida
    Arrate, Maria P.
    Gorska, Agnieszka E.
    Fuller, Londa
    Zhao, Yue
    Stengel, Kristy
    Fischer, Melissa A.
    Stubbs, Matthew C.
    Liu, Phillip C. C.
    Boyd, Kelli
    Rathmell, Jeffrey C.
    Hiebert, Scott W.
    Savona, Michael R.
    CLINICAL CANCER RESEARCH, 2021, 27 (02) : 598 - 607
  • [24] Dronabinol has preferential antileukemic activity in acute lymphoblastic and myeloid leukemia with lymphoid differentiation patterns
    Kerstin Maria Kampa-Schittenhelm
    Olaf Salitzky
    Figen Akmut
    Barbara Illing
    Lothar Kanz
    Helmut Rainer Salih
    Marcus Matthias Schittenhelm
    BMC Cancer, 16
  • [25] Activity of Carfilzomib (CFZ) in Acute Myeloid Leukemia (AML) As a Single Agent and in Novel Combinations
    Peng, Mao Yu
    Abaza, Yasmin
    Mcdermott, Martina
    Mead, Monica
    Slamon, Dennis J.
    Larson, Sarah
    BLOOD, 2020, 136
  • [26] Significant preclinical antileukemic activity of the tyrosine kinase inhibitor BVT I in acute myeloid leukemia
    Eriksson, S.
    Hassan, S.
    Hoglund, M.
    Larsson, R.
    Lindhagen, E.
    Aleskog, A.
    Lothgren, A.
    Fohlenhag, K.
    Jensen, A. Jenmalm
    Parrow, V.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 114 - 115
  • [27] Cotargeting of XPO1 Enhances the Antileukemic Activity of Midostaurin and Gilteritinib in Acute Myeloid Leukemia
    Brinton, Lindsey T.
    Sher, Steven
    Williams, Katie
    Canfield, Daniel
    Orwick, Shelley
    Wasmuth, Ronni
    Cempre, Casey
    Skinner, Jordan
    Lehman, Amy
    Blachly, James S.
    Byrd, John C.
    Lapalombella, Rosa
    CANCERS, 2020, 12 (06) : 1 - 15
  • [28] New drugs in acute myeloid leukemia
    Kadia, T. M.
    Ravandi, F.
    Cortes, J.
    Kantarjian, H.
    ANNALS OF ONCOLOGY, 2016, 27 (05) : 770 - 778
  • [29] New drugs in acute myeloid leukemia
    Estey, Elihu
    SEMINARS IN ONCOLOGY, 2008, 35 (04) : 439 - 448
  • [30] NEW DRUGS IN ACUTE MYELOID LEUKEMIA
    Ferrara, F.
    HAEMATOLOGICA, 2019, 104 : 216 - 218
12345